-
Mashup Score: 158BrainChild Bio, Inc. - 1 year(s) ago
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology platform to adult indications.
Source: brainchildbio.comCategories: General Medicine News, Oncologists1Tweet
It's been a dream to bring better treatments to kids with #DIPG & #CNStumors. It's thrilling to announce #BrainChildBio a kids first biotech advancing #CARTcells for CNS tumors (CEO Steve Brugger; CSO Mike Jensen, MD) in partnership with @seattlechildren. https://t.co/6KGGE22gbL